# Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy

> **NCT04642911** · — · ACTIVE_NOT_RECRUITING · sponsor: **Ukraine Association of Biobank** · enrollment: 91 (actual)

## Conditions studied

- Diabete Type 2
- Mesenchymal Stem Cell

## Interventions

- **OTHER:** Long term follow up

## Key facts

- **NCT ID:** NCT04642911
- **Lead sponsor:** Ukraine Association of Biobank
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-10-15
- **Primary completion:** 2021-09-01
- **Final completion:** 2030-10-10
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2021-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04642911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04642911, "Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04642911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*